111 related articles for article (PubMed ID: 10687143)
1. c-erbB-2 and episialin challenge host immune response by HLA class I expression in human non-small-cell lung cancer.
Koukourakis MI; Giatromanolaki A; Guddo F; Kaklamanis L; Vignola M; Kakolyris S; Turley H; Georgoulias V; Bonsignore G; Gatter KC; Harris AL
J Immunother; 2000 Jan; 23(1):104-14. PubMed ID: 10687143
[TBL] [Abstract][Full Text] [Related]
2. MUC1 (episialin) expression in non-small cell lung cancer is independent of EGFR and c-erbB-2 expression and correlates with poor survival in node positive patients.
Guddo F; Giatromanolaki A; Koukourakis MI; Reina C; Vignola AM; Chlouverakis G; Hilkens J; Gatter KC; Harris AL; Bonsignore G
J Clin Pathol; 1998 Sep; 51(9):667-71. PubMed ID: 9930070
[TBL] [Abstract][Full Text] [Related]
3. Expression of hypoxia-inducible carbonic anhydrase-9 relates to angiogenic pathways and independently to poor outcome in non-small cell lung cancer.
Giatromanolaki A; Koukourakis MI; Sivridis E; Pastorek J; Wykoff CC; Gatter KC; Harris AL
Cancer Res; 2001 Nov; 61(21):7992-8. PubMed ID: 11691824
[TBL] [Abstract][Full Text] [Related]
4. HLA class I antigen expression is associated with a favorable prognosis in early stage non-small cell lung cancer.
Kikuchi E; Yamazaki K; Torigoe T; Cho Y; Miyamoto M; Oizumi S; Hommura F; Dosaka-Akita H; Nishimura M
Cancer Sci; 2007 Sep; 98(9):1424-30. PubMed ID: 17645781
[TBL] [Abstract][Full Text] [Related]
5. Loss of antigen-presenting molecules (MHC class I and TAP-1) in lung cancer.
Korkolopoulou P; Kaklamanis L; Pezzella F; Harris AL; Gatter KC
Br J Cancer; 1996 Jan; 73(2):148-53. PubMed ID: 8546899
[TBL] [Abstract][Full Text] [Related]
6. The positive prognostic effect of stromal CD8+ tumor-infiltrating T cells is restrained by the expression of HLA-E in non-small cell lung carcinoma.
Talebian Yazdi M; van Riet S; van Schadewijk A; Fiocco M; van Hall T; Taube C; Hiemstra PS; van der Burg SH
Oncotarget; 2016 Jan; 7(3):3477-88. PubMed ID: 26658106
[TBL] [Abstract][Full Text] [Related]
7. bcl-2 and c-erbB-2 proteins are involved in the regulation of VEGF and of thymidine phosphorylase angiogenic activity in non-small-cell lung cancer.
Koukourakis MI; Giatromanolaki A; O'Byrne KJ; Cox J; Krammer B; Gatter KC; Harris AL
Clin Exp Metastasis; 1999; 17(7):545-54. PubMed ID: 10845553
[TBL] [Abstract][Full Text] [Related]
8. Clinical significance of expression of cancer/testis antigen and down-regulation of HLA class-I in patients with stage I non-small cell lung cancer.
Hanagiri T; Shigematsu Y; Shinohara S; Takenaka M; Oka S; Chikaishi Y; Nagata Y; Baba T; Uramoto H; So T; Yamada S
Anticancer Res; 2013 May; 33(5):2123-8. PubMed ID: 23645764
[TBL] [Abstract][Full Text] [Related]
9. The absence of HLA class I expression in non-small cell lung cancer correlates with the tumor tissue structure and the pattern of T cell infiltration.
Perea F; Bernal M; Sánchez-Palencia A; Carretero J; Torres C; Bayarri C; Gómez-Morales M; Garrido F; Ruiz-Cabello F
Int J Cancer; 2017 Feb; 140(4):888-899. PubMed ID: 27785783
[TBL] [Abstract][Full Text] [Related]
10. Expansion of quiescent lung adenocarcinoma CD8+ T cells by MUC1-8-mer peptide-T2 cell-β2 microglobulin complexes.
Atzin-Méndez JA; López-González JS; Báez R; Arenas-Del Angel MC; Montaño LF; Silva-Adaya D; Lascurain R; Gorocica P
Oncol Rep; 2016 Jan; 35(1):33-42. PubMed ID: 26498650
[TBL] [Abstract][Full Text] [Related]
11. Expression of major histocompatibility class I and class II antigens and intercellular adhesion molecule-1 on operable non-small cell lung carcinomas: frequency and prognostic significance.
Passlick B; Izbicki JR; Simmel S; Kubuschok B; Karg O; Habekost M; Thetter O; Schweiberer L; Pantel K
Eur J Cancer; 1994; 30A(3):376-81. PubMed ID: 8204362
[TBL] [Abstract][Full Text] [Related]
12. The anti-MUC1 monoclonal antibody BCP8 can be used to isolate and identify putative major histocompatibility complex class I associated amino acid sequences.
Agrawal B; Reddish MA; Christian B; VanHeele A; Tang L; Koganty RR; Longenecker BM
Cancer Res; 1998 Nov; 58(22):5151-6. PubMed ID: 9823326
[TBL] [Abstract][Full Text] [Related]
13. Cytotoxic properties of CD4(+) T-cell clones which lyse HLA class II negative autologous non-small-cell lung cancer cells.
Semino C; Ferlazzo G; Ratto GB; Melioli G
Cell Immunol; 1999 Sep; 196(2):87-94. PubMed ID: 10527560
[TBL] [Abstract][Full Text] [Related]
14. Tecemotide: an antigen-specific cancer immunotherapy.
Wurz GT; Kao CJ; Wolf M; DeGregorio MW
Hum Vaccin Immunother; 2014; 10(11):3383-93. PubMed ID: 25483673
[TBL] [Abstract][Full Text] [Related]
15. Vascular endothelial growth factor, wild-type p53, and angiogenesis in early operable non-small cell lung cancer.
Giatromanolaki A; Koukourakis MI; Kakolyris S; Turley H; O'Byrne K; Scott PA; Pezzella F; Georgoulias V; Harris AL; Gatter KC
Clin Cancer Res; 1998 Dec; 4(12):3017-24. PubMed ID: 9865915
[TBL] [Abstract][Full Text] [Related]
16. Is downregulation of MHC class I antigen expression in human non-small cell lung cancer associated with prolonged survival?
Ramnath N; Tan D; Li Q; Hylander BL; Bogner P; Ryes L; Ferrone S
Cancer Immunol Immunother; 2006 Aug; 55(8):891-9. PubMed ID: 16187081
[TBL] [Abstract][Full Text] [Related]
17. Analysis of cytotoxic T lymphocytes and Fas/FasL in Japanese patients with non-small cell lung cancer associated with HLA-A2.
Yoshimura C; Nomura S; Kanazawa S; Kuwana M; Muramatsu M; Yamaguchi K; Fukuhara S
J Cancer Res Clin Oncol; 2002 Nov; 128(11):581-8. PubMed ID: 12458337
[TBL] [Abstract][Full Text] [Related]
18. Lack and restoration of sensitivity of lung cancer cells to cellular attack with special reference to expression of human leukocyte antigen class I and/or major histocompatibility complex class I chain related molecules A/B.
Baba T; Hanagiri T; Ichiki Y; Kuroda K; Shigematsu Y; Mizukami M; Sugaya M; Takenoyama M; Sugio K; Yasumoto K
Cancer Sci; 2007 Nov; 98(11):1795-802. PubMed ID: 17725806
[TBL] [Abstract][Full Text] [Related]
19. Functional detection of epithelial cell adhesion molecule specific cytotoxic T lymphocytes in patients with lung cancer, colorectal cancer and in healthy donors.
Trojan A; Tun-Kyi A; Odermatt B; Nestle FO; Stahel RA
Lung Cancer; 2002 May; 36(2):151-8. PubMed ID: 11955649
[TBL] [Abstract][Full Text] [Related]
20. Prolonged survival of patients with lung adenocarcinoma expressing XAGE-1b and HLA class I antigens.
Kikuchi E; Yamazaki K; Nakayama E; Sato S; Uenaka A; Yamada N; Oizumi S; Dosaka-Akita H; Nishimura M
Cancer Immun; 2008 Aug; 8():13. PubMed ID: 18752338
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]